TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 347, Issue 4, 2006, Pages 1113-1120

  Patel, Devang N ^a,b   Bailey, Steven R ^a,b   Gresham, John K ^a,b   Schuchman, David B ^a,b   Shelhamer, James H ^b,c   Goldstein, Barry J ^b,d   Foxwell, Brian M ^b,e   Stemerman, Michael B ^b,f   Maranchie, Jodi K ^b,g   Valente, Anthony J ^a,b   Mummidi, Srinivas ^a,b   Chandrasekar, Bysani ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Coronary disease; Endotoxins; MAP kinase; Signal transduction

Indexed keywords

ANTIBODY; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCL16; CHEMOKINE RECEPTOR CXCR6; FLAVOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; PROTEIN NOX4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE VECTOR; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANTIGENS, CD14; CELLS, CULTURED; HUMANS; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; POLYMYXIN B; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

BACTERIA (MICROORGANISMS);

EID: 33746324819     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.015     Document Type: Article

References (35)

1. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610-621
2. Sheikine Y., and Hansson G.K. Chemokines and atherosclerosis. Ann. Med. 36 (2004) 98-118
3. Shimaoka T., Nakayama T., Kume N., Takahashi S., Yamaguchi J., Minami M., Hayashida K., Kita T., Ohsumi J., Yoshie O., and Yonehara S. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 171 (2003) 1647-1651
4. Wilbanks A., Zondlo S.C., Murphy K., Mak S., Soler D., Langdon P., Andrew D.P., Wu L., and Briskin M. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166 (2001) 5145-5154
5. Abel S., Hundhausen C., Mentlein R., Schulte A., Berkhout T.A., Broadway N., Hartmann D., Sedlacek R., Dietrich S., Muetze B., Schuster B., Kallen K.J., Saftig P., Rose-John S., and Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172 (2004) 6362-6372
6. Matloubian M., David A., Engel S., Ryan J.E., and Cyster J.G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1 (2000) 298-304
7. Liao F., Alkhatib G., Peden K.W., Sharma G., Berger E.A., and Farber J.M. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185 (1997) 2015-2023
8. Deng H.K., Unutmaz D., KewalRamani V.N., and Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388 (1997) 296-300
9. Loetscher M., Amara A., Oberlin E., Brass N., Legler D., Loetscher P., D'Apuzzo M., Meese E., Rousset D., Virelizier J.L., Baggiolini M., Arenzana-Seisdedos F., and Moser B. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr. Biol. 7 (1997) 652-660
10. i, phosphatidylinositol 3-kinase, Akt, IκB kinase, and nuclear factor-κB and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J. Biol. Chem. 279 (2004) 3188-3196
11. Minami M., Kume N., Shimaoka T., Kataoka H., Hayashida K., Yonehara S., and Kita T. Expression of scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX) in human atheroma. Ann. N Y Acad. Sci. 947 (2001) 373-376
12. Y. Sheikine, C.S. Bang, L. Nilsson, A. Samnegard, A. Hamsten, L. Jonasson, P. Eriksson, A. Sirsjo, Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. Atherosclerosis, in press.
13. Wuttge D.M., Zhou X., Sheikine Y., Wagsater D., Stemme V., Hedin U., Stemme S., Hansson G.K., and Sirsjo A. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 750-755
14. Wagsater D., Olofsson P.S., Norgren L., Stenberg B., and Sirsjo A. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Biochem. Biophys. Res. Commun. 325 (2004) 1187-1193
15. Xu H., Xu W., Chu Y., Gong Y., Jiang Z., and Xiong S. Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesion. Infect. Immun. 73 (2005) 4007-4016
16. Kim C.H., Kunkel E.J., Boisvert J., Johnston B., Campbell J.J., Genovese M.C., Greenberg H.B., and Butcher E.C. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107 (2001) 595-601
17. Andreakos E., Sacre S.M., Smith C., Lundberg A., Kiriakidis S., Stonehouse T., Monaco C., Feldmann M., and Foxwell B.M. Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103 (2004) 2229-2237
18. Yang X., Coriolan D., Murthy V., Schultz K., Golenbock D.T., and Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1069-H1076
19. Chandrasekar B., Valente A.J., Freeman G.L., Mahimainathan L., and Mummidi S. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-κB-dependent PTEN activation. Biochem. Biophys. Res. Commun. 339 (2006) 956-963
20. Wang N., Verna L., Hardy S., Zhu Y., Ma K.S., Birrer M.J., and Stemerman M.B. c-Jun triggers apoptosis in human vascular endothelial cells. Circ. Res. 85 (1999) 387-393
21. Mahadev K., Motoshima H., Wu X., Ruddy J., Arnold R., Cheng G., Lambeth J., and Goldstein B. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24 (2004) 1844-1854
22. Chandrasekar B., Mummidi S., Valente A.J., Patel D.N., Bailey S.R., Freeman G.L., Hatano M., Tokuhisa T., and Jensen L.E. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J. Biol. Chem. 280 (2005) 26263-26277
23. Maranchie J.K., and Zhan Y. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65 (2005) 9190-9193
24. Zhong J., and Kyriakis J.M. Germinal center kinase is required for optimal Jun N-terminal kinase activation by Toll-like receptor agonists and is regulated by the ubiquitin proteasome system and agonist-induced, TRAF6-dependent stabilization. Mol. Cell. Biol. 24 (2004) 9165-9175
25. Wan J., Sun L., Mendoza J.W., Chui Y.L., Huang D.P., Chen Z.J., Suzuki N., Suzuki S., Yeh W.C., Akira S., Matsumoto K., Liu Z.G., and Wu Z. Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1. Mol. Cell. Biol. 24 (2004) 192-199
26. Stoll L.L., Denning G.M., and Weintraub N.L. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2227-2236
27. Koprak S., Matheravidathu S., Springer M., Gould S., and Dumont F.J. Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin. Cell Immunol. 223 (2003) 1-12
28. Unutmaz D., Xiang W., Sunshine M.J., Campbell J., Butcher E., and Littman D.R. The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J. Immunol. 165 (2000) 3284-3292
29. Sato T., Thorlacius H., Johnston B., Staton T.L., Xiang W., Littman D.R., and Butcher E.C. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J. Immunol. 174 (2005) 277-283
30. Zhuge X., Murayama T., Arai H., Yamauchi R., Tanaka M., Shimaoka T., Yonehara S., Kume N., Yokode M., and Kita T. CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 331 (2005) 1295-1300
31. Ludwig A., Schulte A., Schnack C., Hundhausen C., Reiss K., Brodway N., Held-Feindt J., and Mentlein R. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J. Neurochem. 93 (2005) 1293-1303
32. Huang Y., Zhu X.Y., Du M.R., Wu X., Wang M.Y., and Li D.J. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner. Hum. Reprod. 21 (2006) 1083-1091
33. Nanki T., Shimaoka T., Hayashida K., Taniguchi K., Yonehara S., and Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis. Rheum. 52 (2005) 3004-3014
34. Agostini C., Cabrelle A., Calabrese F., Bortoli M., Scquizzato E., Carraro S., Miorin M., Beghe B., Trentin L., Zambello R., Facco M., and Semenzato G. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in Sarcoidosis. Am. J. Respir. Crit. Care Med. 172 (2005) 1290-1298
35. Park H.S., Jung H.Y., Park E.Y., Kim J., Lee W.J., and Bae Y.S. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173 (2004) 3589-3593